Skip to main content

Osiris keeps losses down, investors reward shares

Shares of stem-cell maker Osiris Therapeutics leap after the company is able to cut losses to half of what analysts expected.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.